M
Magnetar Capital Partners, LP
+ Con en carteraCXII
+4.93%
Rentabilidad a 3 meses
$10.335
+0.005 (+0.05%)Al cierre
Loading chart…
- Máximo
- 10.350
- Apertura
- 10.320
- Precio medio ponderado por volumen
- 10.34
- Volumen
- 343.54K
- Capitalización
- —
- Mínimo
- 10.320
- Importe
- 3.55M
- EV/EBITDA, TTM
- 0.00
Churchill Capital Corp XII is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has conducted no operations and has generated no revenue.
Análisis de IA of Churchill Capital Corp XII (CXII)
MantenerChurchill Capital Corp XII (CXII) is currently trading at $10.34, which is close to its 200-day simple moving average of $10.64, indicating a potential support level. The RSI is at 32.11, suggesting that the stock is oversold, which could indicate a buying opportunity, but caution is warranted due to its high P/E ratio of 258.99 and negative earnings in Q1 2026. The stock has shown a 5-day change of -0.14% and a 20-day change of -4.22%, reflecting a downward trend. The main risk is the current ratio of 12.07 in Q2, which, while indicating good liquidity, follows a very low ratio of 0.04 in Q1, suggesting volatility in financial health.
Métricas de valoración
El PER previsto actual de Churchill Capital Corp XII (CXII) es 0.00, frente a su media de 5 años de .
Ballenas con CXII en cartera
Preguntas frecuentes sobre CXII, respondidas por Alphio AI
Churchill Capital Corp XII is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has conducted no operations and has generated no revenue. It operates in the Financials sector.
Churchill Capital Corp XII (CXII) is currently trading at $10.34, which is close to its 200-day simple moving average of $10.64, indicating a potential support level. The RSI is at 32.11, suggesting that the stock is oversold, which could indicate a buying opportunity, but caution is warranted due to its high P/E ratio of 258.99 and negative earnings in Q1 2026. The stock has shown a 5-day change of -0.14% and a 20-day change of -4.22%, reflecting a downward trend. The main risk is the current ratio of 12.07 in Q2, which, while indicating good liquidity, follows a very low ratio of 0.04 in Q1, suggesting volatility in financial health.
Comunidad
Más ↗Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.